Preventing hypokalemia in critically ill patients

Area of Science:

• Critical Care Medicine
• Clinical Pharmacology
• Nephrology

Background:

• Critical care therapies often lead to potassium depletion.
• Current practice involves reactive potassium replacement after hypokalemia develops.
• Reactive potassium bolus therapy poses risks, incurs costs, and increases nursing burden.

Purpose of the Study:

• To evaluate the efficacy of preemptive potassium administration in maintenance intravenous fluids.
• To determine if proactive potassium supplementation prevents hypokalemia.
• To assess the impact on the requirement for potassium bolus therapy.

Main Methods:

• Retrospective review of 156 adult patients with normal admission potassium and creatinine, excluding those on total parenteral nutrition.
• Patients were divided into a treatment group (n=76) receiving 36-72 mmol/day potassium in maintenance IV fluids and a control group (n=80).
• Comparison of potassium bolus frequency and associated costs between the groups.

Main Results:

• The preemptive potassium group received significantly fewer potassium boluses (0.8 vs. 2.73, P < .001).
• No significant differences in demographics or admission characteristics between groups.
• Mean cost savings of $231 per patient in the treatment group.

Conclusions:

• Maintenance intravenous potassium (72-144 mmol/L per day) is beneficial for patients with normal admission electrolytes.
• Proactive potassium administration prevents hypokalemic events, reduces invasive procedures, lowers costs, and decreases nursing care requirements.
• This strategy optimizes patient care and resource utilization in critical care settings.